3 Stocks to Monitor That Increased Dividends During Market Turbulence
Market Volatility and Consumer Confidence: Wall Street is experiencing volatility due to high inflation and uncertainty regarding Federal Reserve rate cuts, with consumer confidence hitting record lows as the year ends.
Dividend-Paying Stocks as Investment Options: Investors are considering dividend-paying stocks like Orange County Bancorp, Dillard's, and United Bankshares for steady income amidst market fluctuations.
Federal Reserve's Interest Rate Decisions: The Federal Reserve has cut interest rates recently but faces challenges with high inflation, leading to uncertainty about future rate cuts.
Emergence of Quantum Computing: Quantum computing is rapidly advancing, with major tech companies integrating it into their infrastructure, presenting new investment opportunities in this emerging field.
Get Free Real-Time Notifications for Any Stock
Analyst Views on OBT
About OBT
About the author
Oxford BioTherapeutics Partners with GSK to Advance Novel Cancer Therapies
- Strategic Collaboration: Oxford BioTherapeutics (OBT) has entered a multi-year strategic collaboration with GSK to leverage OBT's OGAP®-Verify platform for identifying multiple novel oncology targets, aiming to develop first-in-class antibody-based cancer therapeutics, showcasing OBT's strong potential in oncology innovation.
- Financial Support: Under the agreement, OBT will receive an undisclosed upfront payment from GSK and may be eligible for downstream milestone payments and royalties on net sales, providing crucial funding to support OBT's research and development pipeline.
- Technological Advantage: OBT's OGAP®-Verify platform enhances target identification sensitivity and specificity, supporting the development of differentiated antibody-based therapies, which not only boosts OBT's R&D capabilities but may also accelerate the time-to-market for new drugs, addressing unmet patient needs.
- Market Outlook: This collaboration marks OBT's second major partnership with a leading global pharmaceutical company this year, reflecting its growing influence in cancer research and is expected to enhance OBT's competitiveness and market share in the global biopharmaceutical landscape.
Daily Upgrade Report for Validea's John Neff Strategy - December 2, 2025
Validea's Low PE Investor Model: Today's upgrades for Validea's Low PE Investor model, based on John Neff's strategy, highlight several stocks with improved ratings due to strong fundamentals and valuations, including Edison International, Mercantile Bank Corp, and others.
Edison International (EIX): This large-cap value stock in the Electric Utilities industry saw its rating increase from 58% to 77%, indicating growing interest based on its fundamentals and valuation.
Mercantile Bank Corp (MBWM): A small-cap value stock in the Money Center Banks industry, its rating improved from 60% to 79%, reflecting positive changes in its underlying fundamentals and stock valuation.
Asbury Automotive Group Inc (ABG): This mid-cap value stock in the Retail (Specialty) industry also experienced a rating increase from 62% to 81%, suggesting strong interest based on its financial performance and valuation metrics.
